Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheridan

Showing results (151-160 of 7,540) with videos related to

Pageof 754
Sort By:
Nature Biotechnology|July 11, 2013
Investors start backing hearing loss treatmentsCormac Sheridan
ANZ Journal of Surgery|March 8, 2013
Practical aspects of clinical photography: part 1--principles, equipment and techniquePeter Sheridan
Nature Biotechnology|December 11, 2012
Belgian biotech's clot-buster approved for aging eyesCormac Sheridan
Nature Biotechnology|December 10, 2013
Phase 3 data for PCSK9 inhibitor wowsCormac Sheridan
Journal of Dental Education|August 1, 1992
Strengthening the NIDR-university relationshipP Sheridan
Critical Care Medicine|May 7, 2002
Specific therapies for inhalation injuryRob Sheridan
The Veterinary Record|March 7, 2020
Are we failing to produce day 1-competent veterinary graduates?John Sheridan
Nature Biotechnology|April 8, 2015
IDO inhibitors move center stage in immuno-oncologyCormac Sheridan
Nature Biotechnology|January 11, 2014
FDA approvals usher in the post-interferon era in HCVCormac Sheridan
Nature Biotechnology|March 18, 2025
Baby genomics: newborn sequencing starts to fulfill its promiseCormac Sheridan
Pageof 754

Showing results (151-160 of 7,540) with videos related to

Sort By:
Pageof 754
Nature Biotechnology|July 11, 2013
Investors start backing hearing loss treatmentsCormac Sheridan
ANZ Journal of Surgery|March 8, 2013
Practical aspects of clinical photography: part 1--principles, equipment and techniquePeter Sheridan
Nature Biotechnology|December 11, 2012
Belgian biotech's clot-buster approved for aging eyesCormac Sheridan
Nature Biotechnology|December 10, 2013
Phase 3 data for PCSK9 inhibitor wowsCormac Sheridan
Journal of Dental Education|August 1, 1992
Strengthening the NIDR-university relationshipP Sheridan
Critical Care Medicine|May 7, 2002
Specific therapies for inhalation injuryRob Sheridan
The Veterinary Record|March 7, 2020
Are we failing to produce day 1-competent veterinary graduates?John Sheridan
Nature Biotechnology|April 8, 2015
IDO inhibitors move center stage in immuno-oncologyCormac Sheridan
Nature Biotechnology|January 11, 2014
FDA approvals usher in the post-interferon era in HCVCormac Sheridan
Nature Biotechnology|March 18, 2025
Baby genomics: newborn sequencing starts to fulfill its promiseCormac Sheridan
Pageof 754